Ispire Technology reports Q1 EPS (10c) vs. (2c) last year

Reports Q1 revenue $39.3M vs. $42.9M last year. Co-CEO Michael Wang commented, “Our results from Q1 2025 reflect our commitment to our growth strategy of becoming the leading innovative vaping technology and precision dosing solutions company worldwide. While our financial results were slightly impacted due to the strategic shifts we have made in our US business to focus on high quality customers and to improve payment terms and gross profit, I am pleased with our team’s overall performance given the challenging macroeconomic environment and look forward to the remainder of fiscal 2025 and the opportunities that lay ahead…we are excited to have recently expanded our global reach through a landmark 5-year master distributor agreement with ANDS for the Middle East and North Affrica region and Global Duty-Free markets. This partnership will enable us to bring our Hidden Hills Club nicotine portfolio to new markets, offering adult consumers innovative, harm-reduced alternatives to combustible cigarettes…” CFO Jim McCormick stated, “The results from our Q1 were in line with our internal projections as we shifted our U.S. strategy while we also had a few delayed shipments which impacted our quarterly results. Despite the obstacles we’ve faced, our Q1 financial performance was still strong, including our gross profit increasing 13.2% year-over-year and our gross margins improving from 16.0% in Q1 2024 to 19.5% in Q1 of 2025.”